Experimental prostate cancer vaccine
Kentr
CSN Member Posts: 111
I just read in Bottom Line Personal (volume 30, number 13, July 1,2009) that there is an experimental vaccine being tested that "...may improve the survival of men with advanced disease."
"If approved by the FDA, Provenge could become an added treatment for late-stage cancer."
This was reported to Bottom Line by Eric J. Small, MD, cancer specialist, University of California, San Francisco, and chief, division of hematology and oncology, UCSF Helen Diller Family Comprehensive Cancer Center.
Kent
"If approved by the FDA, Provenge could become an added treatment for late-stage cancer."
This was reported to Bottom Line by Eric J. Small, MD, cancer specialist, University of California, San Francisco, and chief, division of hematology and oncology, UCSF Helen Diller Family Comprehensive Cancer Center.
Kent
0
Comments
Discussion Boards
- All Discussion Boards
- 6 CSN Information
- 6 Welcome to CSN
- 122.3K Cancer specific
- 2.8K Anal Cancer
- 451 Bladder Cancer
- 310 Bone Cancers
- 1.6K Brain Cancer
- 28.5K Breast Cancer
- 399 Childhood Cancers
- 27.9K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.2K Gynecological Cancers (other than ovarian and uterine)
- 13K Head and Neck Cancer
- 6.4K Kidney Cancer
- 677 Leukemia
- 799 Liver Cancer
- 4.2K Lung Cancer
- 5.1K Lymphoma (Hodgkin and Non-Hodgkin)
- 240 Multiple Myeloma
- 7.2K Ovarian Cancer
- 65 Pancreatic Cancer
- 492 Peritoneal Cancer
- 5.6K Prostate Cancer
- 1.2K Rare and Other Cancers
- 544 Sarcoma
- 740 Skin Cancer
- 658 Stomach Cancer
- 192 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.9K Uterine/Endometrial Cancer
- 6.3K Lifestyle Discussion Boards